News tagged with journal of experimental medicine
Washington State University researchers have developed a new drug candidate that dramatically improves the cognitive function of rats with Alzheimer's-like mental impairment.
Alzheimer's disease & dementia Oct 11, 2012 | 5 / 5 (8) | 7 |
Scientists have discovered why some people may be protected from harmful parasitic worms naturally while others cannot in what could lead to new therapies for up to one billion people worldwide.
Medical research May 05, 2011 | 4.3 / 5 (7) | 1 |
Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments.
Cancer Mar 13, 2013 | 5 / 5 (5) | 0
One kind of leukemia sometimes masquerades as another, according to a study published online this week in the Journal of Experimental Medicine.
Cancer Dec 12, 2011 | 5 / 5 (4) | 0
(Medical Xpress)—New research demonstrates that the cellular metabolism of certain immune cells is closely linked to their function, which includes protecting against viral infections and the development of tumours.
Medical research Dec 24, 2012 | 5 / 5 (4) | 0 |
Two children with an aggressive form of childhood leukemia had a complete remission of their disease-showing no evidence of cancer cells in their bodies-after treatment with a novel cell therapy that reprogrammed their immune ...
Cancer Mar 25, 2013 | 5 / 5 (4) | 0 |
Hitting 'reset' in protein synthesis restores myelination, suggests new treatment for misfolded protein diseases
(Medical Xpress)—A potential new treatment strategy for patients with Charcot-Marie-Tooth disease is on the horizon, thanks to research by neuroscientists now at the University at Buffalo's Hunter James ...
Medical research Apr 26, 2013 | 4.3 / 5 (4) | 0 |
A team of international scientists led by principal investigator Dr. Tak Mak at the Princess Margaret Cancer Centre, University Health Network, has identified a causative link between the product of a mutated metabolic enzyme ...
Cancer Jul 04, 2012 | 5 / 5 (3) | 0 |
(HealthDay)—An experimental therapy for hepatitis C—a "silent killer" linked to liver cancer and cirrhosis—has shown promise in tamping down virus levels in early trials.
Diseases, Conditions, Syndromes Mar 27, 2013 | 5 / 5 (3) | 1 |
(Medical Xpress)—Researchers at The Jackson Laboratory have identified a molecule that prevents repair of some cancer cells, providing a potential new "genetic chemotherapy" approach to cancer treatment ...
Cancer Apr 17, 2013 | 4.7 / 5 (3) | 0 |
(HealthDay) -- Yet another orally taken medication shows some promise in preventing relapse and disability for people with relapsing-remitting multiple sclerosis, a new report suggests.
Diseases, Conditions, Syndromes Mar 14, 2012 | 5 / 5 (2) | 0 |
An agent under consideration for use in PET imaging combats neuronal death to relieve Parkinsonian symptoms in animal models, according to a study published on April 2nd in the Journal of Experimental Medicine.
Parkinson's & Movement disorders Apr 02, 2012 | 5 / 5 (2) | 0
Scientists at the Centre for Addiction and Mental Health (CAMH) have identified a potential new approach to preventing smoking relapse, which occurs frequently in smokers who attempt to quit, despite current treatments.
Health Oct 22, 2012 | 5 / 5 (2) | 0
Despite progress in regenerative medicine, with age, the skin loses its properties in an irreversible manner. The ATIP-Avenir team "Epidermal homeostasis and tumorigenesis" directed by Chloé Féral, an Inserm ...
Medical research Jan 22, 2013 | 5 / 5 (2) | 0
A paper published online on June 13 in the Journal of Experimental Medicine identifies new gene mutations in patients with chronic lymphocytic leukemia (CLL) -- a disease often associated with lack of response to chemotherapy and po ...
Cancer Jun 13, 2011 | 5 / 5 (1) | 0
Journal of Experimental Medicine
The Journal of Experimental Medicine is a peer-reviewed academic journal that publishes research papers and commentaries in the biomedical area. Topics covered include immunology, inflammation, infectious disease, hematopoiesis, cancer, stem cells and vascular biology. The journal has a history of predominantly publishing basic research, although studies in human subjects form an increasing proportion of papers published (around 10% in 2004).
JEM was founded in 1896, which makes it among the longest established of scientific journals. Initially published at the Johns Hopkins University, it was taken over in 1905 by the Rockefeller University Press, the current publishers, and is published on a not-for-profit basis. There is no single Editor-in-Chief, with eleven academic Editors and a hundred strong Advisory Board.
JEM is published monthly. An online archive of articles back to 1896 is available in text and PDF formats (material from 1996 and earlier is only available in PDF). Material over 6 months old is freely accessible, and access to all papers is also provided free of charge to developing countries. All of the content of JEM is also deposited in PubMed Central where it is available to the public 6 months after publication. Copyright to articles remains with the authors and third parties may re-use JEM content under the terms of a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license described at http://creativecommons.org/licenses/by-nc-sa/3.0/.
For more information about Journal of Experimental Medicine, read the full article at
This text uses material from Wikipedia and is available under the GNU Free Documentation License.